Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

NCT00001533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Anemia
Leukemia, T-Cell
Lymphocytosis
Neutropenia
Thrombocytopenia

Interventions

DRUG: cyclosporine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)